IGM Biosciences (NASDAQ:IGMS) 주식

IGM Biosciences

IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, Aplitabart: An IgM antibody targeting Death Receptor 5 (DR5) proteins, for the treatment of colorectal cancer; Imvotamab: A bispecific for severe systemic lupus erythematosus (SLE) and one for severe rheumatoid arthritis (RA); and IGM-2644: A bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins, currently planned for evaluation in autoimmune disease.

Russell,2000,Index.magnifying,Glass,Showing,The,Words.background,Of,Banknotes,And

Analyst Color

Broad U.S. Equity ETFs

Small Cap

ETFs

EVGO

IGMS

LNTH

MORF

OUST

PLSE

SOUN

iShares Russell 2000 ETF가 추적하는 러셀(Russell) 2000 소형주 지수는 2023년 10월 이후 최고의 주간 실적을 기록하여 6% 이상 급등하여 2022년 1월 이후 최고 수준에 도달했다.

러셀 2000 지수, 연중 가장 강한 주를 기록하며 31개월 최고치를 기록

IGM Biosciences Inc

News

Management

National Research Trent Green To Join As CEO On June 1, 2025

<a href="https://ppubs.uspto.gov/api/pdf/downloadPdf/12282973?requestToken=eyJzdWIiOiIyM2Q0ODBmNS1jYzk1LTQ5OGMtYTU3MS1mNzQ0ODQyMjM3MjYiLCJ2ZXIiOiIwOTE2Y2Y5My0xZTJkLTQwOGItOTg0MS05OTQ2MDE0ZjRkNDUiLCJleHAiOjB9" title="https://ppubs.uspto.gov/api/pdf/downloadPdf/12282973?requestToken=eyJzdWIiOiIyM2Q0ODBmNS1jYzk1LTQ5OGMtYTU3MS1mNzQ0ODQyMjM3MjYiLCJ2ZXIiOiIwOTE2Y2Y5My0xZTJkLTQwOGItOTg0MS05OTQ2MDE0ZjRkNDUiLCJleHAiOjB9">https://ppubs.uspto.gov/api/pdf/downloadPdf/12282973?requestToken=eyJzdWIiOiIyM2Q0ODBmNS1jYzk1LTQ5OGMtYTU3MS1mNzQ0ODQyMjM3MjYiLCJ2ZXIiOiIwOTE2Y2Y5My0xZTJkLTQwOGItOTg0MS05OTQ2MDE0ZjRkNDUiLCJleHAiOjB9</a>

NVVE

Nuvve Granted US Patent 12282973 B2 Titled "VIRTUALIZED BATTERY RESOURCES FOR GRID SERVICE PARTICIPATION"

Cantor Fitzgerald initiated coverage on AbbVie Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>), citing the company&#8217;s compelling mix of growth and defense with a differentiated topline profile, good visibility on key near-term drivers with low clinical risk, no significant near-to-mid-term patent loss, and a lack of a major <a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">binary data catalyst over 2025</a>.
&#8220;We acknowledge the pipeline still has a lot to prove, but think it also has limited value ascribed to it, and we see that as more of the &#8217;26 narrative,&#8221; analyst Carter Gould writes.
Also Read: <a target="_blank" href="https://www.benzinga.com/government/regulations/25/04/44851905/trumps-new-order-targets-drug-pricing-transparency-and-medicare-cost-reduction" rel="noreferrer noopener">Trump&#8217;s New Order Targets Drug Pricing Transparency And Medicare Cost Reduction</a>
With AbbVie stock trading around $180 per share—about 14.1 times its expected 2025 earnings, or 16.3 times when including Skyrizi royalties—analyst Gould sees the stock as appealing as it&#8217;s been over the past six months, despite the possibility of higher tariff costs in 2026.
Cantor sees AbbVie&#8217;s immunology drugs, Skyrizi and Rinvoq, as strong and unique in the market. They already have a solid presence and are growing quickly without relying heavily on new clinical trial results. Plus, there&#8217;s no major concern about losing patent protection until after 2033. Recent prescription trends support this view, showing strong overall growth for both drugs. In particular, their use in gastroenterology is a key driver, growing over 40% year-over-year.
Cantor initiated with an Overweight rating and <a target="_blank" href="https://www.benzinga.com/quote/ABBV/analyst-ratings" rel="noreferrer noopener">a price target of 210</a>.
AbbVie is scheduled to release its first quarter <a href="https://www.benzinga.com/pressreleases/25/03/n44559336/abbvie-to-host-first-quarter-2025-earnings-conference-call" target="_blank" rel="noreferrer noopener">earnings on Friday</a>. Analysts estimate $2.51 per share earnings and sales of around $12.91 billion as per data from <a href="https://www.benzinga.com/pro/feature/newsfeed" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
In March, AbbVie and&nbsp;Gubra A/S&nbsp;announced a license agreement to develop GUB014295, a long-acting amylin analog for obesity. GUB014295 is currently in a&nbsp;<a target="_blank" href="https://www.benzinga.com/25/03/44089215/abbvie-becomes-another-big-pharma-to-enter-obesity-treatment-race" rel="noreferrer noopener">Phase 1 clinical trial</a>.
Under the terms of the agreement, AbbVie will lead the development and commercialization activities of GUB014295 globally.
Gubra will receive&nbsp;$350 million&nbsp;in total upfront payment and be eligible to receive up to&nbsp;$1.875 billion&nbsp;in development, commercial and sales milestone payments with tiered royalties on global net sales.
Price Action: ABBV stock was up 2.1% at $173.78 on Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/04/44928729/rigetti-scores-4-6-million-uk-grant-to-tackle-quantum-error-correction" target="_blank" rel="noreferrer noopener">Rigetti Scores $4.6 Million UK Grant To Tackle Quantum Error Correction</a></li>
</ul>
Photo: Shutterstock

Biotech

Large Cap

Health Care

Initiation

Analyst Ratings

General

ABBV

AbbVie's Pipeline May Be A 2026 Story, But Analyst Likes The Setup Now

Capital One Financial Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COF#NYSE">COF</a>) released its first-quarter results after Tuesday's closing bell. Here's a look at the d<a href="https://www.benzinga.com/pressreleases/25/04/b44936314/capital-one-reports-first-quarter-2025-net-income-of-1-4-billion-or-3-45-per-share">etails from the report.&nbsp;</a>
The Details: Capital One reported quarterly earnings of $4.06 per share, which beat the analyst consensus estimate of $3.69. Quarterly revenue came in at $10 billion, which missed the analyst consensus estimate of $10.04 billion and is an increase over revenue of $9.4 billion from the same period last year.
Read Next: <a href="https://www.benzinga.com/25/04/44935272/tesla-reports-q1-after-the-bell-68-expect-the-company-to-miss-analysts-estimates">Will Tesla Beat The Street? 68% Expect Something Markets May Not Be Ready For</a>&nbsp;
For the first quarter, Capital One reported: 
<ul>
<li>Provision for credit losses decreased by $273 million to $2.4 billion.</li>
<li>Net charge-offs of $2.7 billion.</li>
<li>$368 million loan reserve release.</li>
<li>Net interest margin of 6.93%, a decrease of 10 basis points.</li>
<li>Efficiency ratio of 59.02 percent.</li>
<li>Adjusted efficiency ratio of 55.94%.</li>
<li>Adjusted operating efficiency ratio of 43.92%.</li>
</ul>
&#8220;Last week, we received regulatory approval for our acquisition of Discover and we&#8217;re fully mobilized to complete the transaction on May 18,&#8221; said Richard D. Fairbank, CEO of Capital One.
&#8220;The combination of Capital One and Discover will create a leading consumer banking and payments platform with unique capabilities, modern technology, and powerful brands,&#8221; Fairbank added. 
COF Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Capital One stock was down 0.12% after-hours at $170 on Tuesday.  
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/25/04/44903087/amazon-stock-downgraded-price-target-slashed-as-tariffs-create-uncertainty">Amazon Stock Downgraded, Price Target Slashed As Tariffs Create Uncertainty&nbsp;</a></li>
</ul>
Photo: Shutterstock

Earnings

Fintech news covering the emerging Financial Technology services sector

Fintech

After-Hours Center

Movers

Capital One Reports Mixed Q1 Results: EPS Beat, Revenue Misses

CTHR

Charles & Colvard Receives Delisting Notice From Nasdaq

Charles Schwab (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>) has outperformed the market over the past 20 years by 2.65% on an annualized basis producing an average annual return of 10.52%. Currently, Charles Schwab has a market capitalization of $138.88 billion. 
Buying $1000 In SCHW: If an investor had bought $1000 of SCHW stock 20 years ago, it would be worth $7,635.09 today based on a price of $76.58 for SCHW at the time of writing.
<h3>Charles Schwab's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745354715_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

SCHW

Here's How Much $1000 Invested In Charles Schwab 20 Years Ago Would Be Worth Today

Icu Seastar Medical Files Prospectus Relates To Offer & Resale, From Time To Time, Of Up To 3.5 Mln Shares By Selling Securityholder

Bank of America Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) traded higher by 3.79% to $38.32 at market close Tuesday, rebounding alongside broader markets following Monday's sharp sell-off. Investor sentiment improved as <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44930495/wall-street-rebounds-ahead-of-tesla-earnings-dow-adds-1000-points-bitcoin-hits-91000-whats-driving-markets-tuesday">potential easing</a> of geopolitical concerns helped lift major indices.
The S&amp;P 500 gained over 100 points late Tuesday, with all 11 S&amp;P 500 sectors in positive territory. Financials such as <a href="http://4 Bank Stocks To Buy As Earnings Soar">bank stocks</a> led the way, supported by optimism around balance sheet strength and a brief pullback in Treasury yields.
What Happened: Bank of America stock bounced back despite lingering caution tied to President Donald Trump's <a href="https://www.benzinga.com/government/regulations/25/04/44904179/wall-street-sinks-dollar-slides-as-trump-ramps-up-fed-attacks-whats-driving-markets-monday">renewed criticism</a> of Federal Reserve Chair Jerome Powell, which had pressured equities a day earlier.
Read Also: <a href="https://www.benzinga.com/news/25/04/44930518/sofi-expands-access-to-private-markets-whats-going-on">SoFi Expands Access to Private Markets: What&#8217;s Going On?</a>
Investors appear to be refocusing on the bank's recent <a href="https://www.benzinga.com/news/earnings/25/04/44811593/bank-of-america-ceo-says-consumer-continues-to-spend-and-maintain-healthy-credit-quality-sticks-to-annual-outlook">first-quarter results</a>, which included $7.4 billion in net income and 90 cents earnings per share — topping Wall Street expectations.
At a JPMorgan event, U.S. Treasury Secretary Scott Bessent <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44930495/wall-street-rebounds-ahead-of-tesla-earnings-dow-adds-1000-points-bitcoin-hits-91000-whats-driving-markets-tuesday">reportedly hinted</a> at a potential de-escalation in U.S.-China tensions, providing a further lift to risk assets.
While analysts continue to monitor rising credit provisions and macro risks, Tuesday's gains reflect confidence in Bank of America's fundamentals and broader market resilience amid an uncertain policy backdrop.
<h1 class="wp-block-heading">How To Buy BAC Stock</h1>
Besides going to a brokerage platform to purchase a share — or fractional share — of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.
For example, in Bank of America&#8217;s case, it is in the Financials sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, BAC has a 52-week high of $48.08 and a 52-week low of $33.07.
Read Also: •&nbsp;<a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44933432/tesla-in-code-red-situation-as-analyst-flags-6-threats-tied-to-musks-government-role">Tesla In &#8216;Code Red Situation&#8217; As Analyst Flags 6 Threats Tied To Musk&#8217;s Government Role</a>
Photo: Shutterstock

What's Going On With Bank of America (BAC) Shares?

Rosenblatt analyst Mike Genovese maintains Fabrinet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) with a Buy and lowers the price target from $280 to $230.

Price Target

Rosenblatt Maintains Buy on Fabrinet, Lowers Price Target to $230

2025 Earnings and FFO Guidance
Based on current plans and assumptions and subject to the risks and uncertainties more fully described in our Securities and Exchange Commission filings, we are adjusting our 2025 loss per share guidance from $(0.60) - $(0.48) per share to $(0.56) - $(0.46) per share and our 2025 FFO guidance from $0.60 - $0.72 per diluted share to $0.61 - $0.71 per diluted share. This guidance is provided for informational purposes and is subject to change. The following is a reconciliation of the calculation of 2025 FFO and earnings per diluted share:
<figure class="table"> 
<table>
<tbody>
<tr>
<td>Guidance for 2025</td>
<td colspan="3">Range &nbsp;</td>
</tr>
<tr>
<td>Loss per diluted share allocated to common shareholders</td>
<td>$(0.56)</td>
<td>to</td>
<td>$(0.46)</td>
</tr>
<tr>
<td>Plus: real estate depreciation, amortization</td>
<td>1.17</td>
<td>1.17</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>FFO per diluted share</td>
<td>$0.61</td>
<td>to</td>
<td>$0.71</td>
</tr>
</tbody>
</table>
</figure>
Our 2025 FFO key assumptions include:
<ul>
<li>Year-end Core Occupancy Range: 88-89%;</li>
<li>Year-end Core Leased Range: 89-90%;</li>
<li>Rental Rate Mark-to-Market (accrual): 3-4%;</li>
<li>Rental Rate Mark-to-Market (cash): (3)-(2)%;</li>
<li>Same Store (accrual) NOI Range: (1)-1%;</li>
<li>Same Store (cash) NOI Range: 1-3%;</li>
<li>Speculative Revenue Target: $27.0 - $28.0 million, $25.4 million achieved;</li>
<li>Tenant Retention Rate Range: 59-61%;</li>
<li>Property Acquisition Activity: None;</li>
<li>Property Sales Activity (excluding land): $40.0-$60.0 million;</li>
<li>Development Starts: One Start;</li>
<li>Financing Activity: We repaid our $70 million unsecured term loan on the scheduled February 2025 maturity date and plan to refinance our $50.0 million construction loan (scheduled to mature August 2026);</li>
<li>Share Buyback Activity: None; and</li>
<li>Annual earnings and FFO per diluted share based on 179.0 million fully diluted weighted average common shares.</li>
</ul>
Except as outlined in our 2025 business plan included in the Supplemental Information Package, our estimates do not include (1) possible future gains or losses or the impact on operating results from other possible future property acquisitions or dispositions, (2) the impacts of any other capital markets activity, (3) future write-offs or reinstatements of accounts receivable and accrued rent balances, or (4) future impairment charges. EPS estimates may fluctuate based on several factors, including changes in the recognition of depreciation and amortization expense, impairment losses on depreciable real estate, and any gains or losses associated with disposition activity. Management is not able to assess at this time the potential impact of these factors on projected EPS. By definition, FFO does not include real estate-related depreciation and amortization, impairment losses on depreciable real estate, or gains or losses associated with disposition activities or depreciable real estate. For a complete definition of FFO and statements of the reasons why management believes FFO provides useful information to investors, see page 40 in our first quarter supplement information package. There can be no assurance that our actual results will not differ materially from the estimates set forth below.

Guidance

Brandywine Realty Trust Narrows FY25 EPS From $(0.60)-$(0.48) To $(0.56)-$(0.46); FY25 FFO From $0.60-$0.72 To $0.61-$0.71 Per Diluted Share

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed up 55.56% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed up 35.14% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CBDY">Target Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBDY#OTC">CBDY</a>) shares closed up 15.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Glb Inv</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed up 14.15% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/CGC">Canopy Gwth</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) shares closed up 9.26% at $1.18</li>
<li><a href="https://www.benzinga.com/quote/BBRRF">Blueberries Medical</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed up 8.42% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed up 8.12% at $0.19</li>
<li><a href="https://www.benzinga.com/quote/CXXIF">C21 Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed up 7.65% at $0.14</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed up 6.24% at $0.27</li>
<li><a href="https://www.benzinga.com/quote/OGI">Organigram Global</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>) shares closed up 6.00% at $1.06</li>
<li><a href="https://www.benzinga.com/quote/CWBHF">Charlottes Web Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CWBHF#OTC">CWBHF</a>) shares closed up 5.81% at $0.09</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed up 5.52% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/VFF">Village Farms Intl</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) shares closed up 4.90% at $0.64</li>
<li><a href="https://www.benzinga.com/quote/TCNNF">Trulieve Cannabis</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) shares closed up 4.16% at $3.90</li>
<li><a href="https://www.benzinga.com/quote/CURLF">Curaleaf Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) shares closed up 3.99% at $0.89</li>
<li><a href="https://www.benzinga.com/quote/CRLBF">Cresco Labs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>) shares closed up 3.67% at $0.65</li>
<li><a href="https://www.benzinga.com/quote/SMG">Scotts Miracle Gro</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) shares closed up 3.31% at $53.07</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/MGWFF">Maple Leaf Green World</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MGWFF#OTC">MGWFF</a>) shares closed down 44.28% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/LMLLF">Pharmadrug</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LMLLF#OTC">LMLLF</a>) shares closed down 28.89% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed down 22.64% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/LVRLF">CordovaCann</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LVRLF#OTC">LVRLF</a>) shares closed down 17.11% at $0.07</li>
<li><a href="https://www.benzinga.com/quote/BLGVF">Belgravia Hartford Cap</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BLGVF#OTC">BLGVF</a>) shares closed down 14.29% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed down 13.00% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/FUAPF">Global Compliance</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FUAPF#OTC">FUAPF</a>) shares closed down 10.26% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CRBP">Corbus Pharmaceuticals</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed down 3.97% at $6.69</li>
<li><a href="https://www.benzinga.com/quote/GRWG">GrowGeneration</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) shares closed down 3.91% at $0.93</li>
<li><a href="https://www.benzinga.com/quote/SOL">Emeren Group</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) shares closed down 3.49% at $1.24</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Cannabis

Markets

BBRRF

BLGVF

CBDY

CNBX

CRBP

CRLBF

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

CWBHF

CXXIF

FFNTF

FUAPF

GNLN

GRWG

LEAFBUYER TECHNOLOGIES by Leafbuyer Technologies, Inc.

LBUY

LMLLF

LVRLF

MGWFF

NWVCF

OILFF

SOLCF

TCNNF

TGIFF

Cannabis Stock Movers For April 22, 2025

Rosenblatt analyst Mike Genovese maintains Cisco Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>) with a Buy and lowers the price target from $80 to $63.

CSCO

Rosenblatt Maintains Buy on Cisco Systems, Lowers Price Target to $63

HAMILTON, Bermuda, 22 April, 2025, 10.30 pm CET – Golden Ocean Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOGL#NASDAQ">GOGL</a>, Euronext Oslo Børs: GOGL))) ("Golden Ocean") and CMB.TECH NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMBT#NYSE">CMBT</a>, Euronext Brussels: CMBT))) ("CMB.TECH") are pleased to announce that they have signed a term sheet (the "Term Sheet") for a contemplated stock-for-stock merger, with CMB.TECH as the surviving entity, based on an exchange ratio of 0.95 shares of CBM.TECH for each share of Golden Ocean (the "Exchange Ratio"), subject to customary adjustments.
The Term Sheet has been unanimously approved by Golden Ocean's Board of Directors, including its special transaction committee composed of disinterested directors (the "Transaction Committee"), and by CMB.TECH's Supervisory Board. As part of this, the Transaction Committee has received a fairness opinion from its financial advisor DNB Markets, part of DNB Bank ASA, concluding that the Exchange Ratio is fair from a financial point of view to Golden Ocean's shareholders.
The transaction would be structured as a merger with Golden Ocean merging with and into CMB.TECH Bermuda Ltd., a wholly-owned subsidiary of CMB.TECH (the "Merger"). Existing shares of Golden Ocean, which are not (directly or indirectly) owned by CMB.TECH, will be cancelled and ultimately exchanged for newly issued CMB.TECH shares at an exchange ratio of 0.95 shares of CBM.TECH for each share of Golden Ocean, subject to customary adjustments, including to reflect share buybacks, share issuances and/or dividend distributions that may take place prior to completion of the Merger. Upon completion of the Merger, 95,952,934 new shares of CMB.TECH would be issued, whereby CMB.TECH shareholders would own approximately 70% of the total issued share capital of the combined company (or 67% excluding treasury shares) and Golden Ocean shareholders would own approximately 30% (or 33% excluding treasury shares), assuming the Exchange Ratio is not adjusted.
The Merger will create one of the largest diversified listed maritime groups in the world with a combined fleet of more than 250 vessels.

CMBT

GOGL

Golden Ocean Group And CMB.TECH NV Announces They Have Signed A Term Sheet For A Contemplated Stock-For-Stock Merger, With CMB.TECH NV As The Surviving Entity

Brandywine Realty Tr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BDN#NYSE">BDN</a>) reported quarterly earnings of $0.14 per share which missed the analyst consensus estimate of $0.16 by 12.5 percent. This is a 41.67 percent decrease over earnings of $0.24 per share from the same period last year. The company reported quarterly sales of $121.52 million which beat the analyst consensus estimate of $120.69 million by 0.68 percent. This is a 3.93 percent decrease over sales of $126.48 million the same period last year.

Earnings Beats

Earnings Misses

Brandywine Realty Tr Q1 FFO $0.14 Misses $0.16 Estimate, Sales $121.52M Beat $120.69M Estimate

FS Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSBW#NASDAQ">FSBW</a>) reported quarterly earnings of $1.01 per share which beat the analyst consensus estimate of $0.93 by 8.6 percent. This is a 4.72 percent decrease over earnings of $1.06 per share from the same period last year. The company reported quarterly sales of $36.11 million which beat the analyst consensus estimate of $36.04 million by 0.18 percent. This is a 1.84 percent increase over sales of $35.46 million the same period last year.

FSBW

FS Bancorp Q1 EPS $1.01 Beats $0.93 Estimate, Sales $36.11M Beat $36.04M Estimate

Jimmy Donaldson, better known as MrBeast is not your average 26-year-old. He's also not your average millionaire. As the most-followed content creator in the world, MrBeast has turned viral stunts, philanthropic giveaways, and high-stakes YouTube challenges into a billion-dollar empire. From surviving in ice for 24 hours to hosting a $5 million Amazon reality show, Donaldson has rewritten the rules of internet fame and stacked a serious fortune in the process.
He doesn't just create content. He creates ecosystems. He reinvests hundreds of millions of dollars into his videos, runs a snack company, has signed a nine-figure streaming deal, and operates a philanthropic brand that donates everything it earns. In short, if you've ever asked how much MrBeast is worth, the answer is: a lot more than you&#8217;d expect for someone who once counted to 100,000 on camera.
<h2 class="wp-block-heading">What is MrBeast's Net Worth in April 2025?</h2>
<a href="https://www.celebritynetworth.com/richest-businessmen/producers/jimmy-donaldson-aka-mrbeast-net-worth/">MrBeast's net worth is currently estimated at $1 billion, according to Celebrity Net Worth.</a> That figure accounts for revenue from his YouTube empire, business ventures like Feastables, merchandise sales, brand sponsorships, and a massive content deal with Amazon.
<a href="https://www.forbes.com/sites/stevenbertoni/2024/10/28/top-creators-2024-the-influencers-turning-buzz-into-billions/">In 2024, Donaldson reportedly earned $85 million from content and brand partnerships alone, according to Forbes.</a> In interviews, Donaldson has claimed that his overall revenue across all ventures ranges from $600 million to $700 million annually, most of which is reinvested directly into video production, expansion, and team growth.
His net worth is soaring, but don't expect him to slow down. He told Time magazine in 2024, "I&#8217;ve reinvested everything to the point of you could claim stupidity&#8230; And it&#8217;s worked out."
Don&#8217;t Miss: 
<ul>
<li>Maximize saving for your retirement and cut down taxes: <a href="https://smartasset.com/retirement/find-a-financial-planner?utm_source=benzinga&amp;utm_campaign=ben&amp;utm_content=y2_5MilNestEgg">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.&nbsp;</li>
<li>It's no wonder Jeff Bezos holds over $250 million in art —&nbsp;<a href="https://www.masterworks.com/?ref=zdbimty&amp;utm_source=Benzinga&amp;utm_medium=affiliate&amp;utm_campaign=Benzinga+Newsgen" target="_blank" rel="noreferrer noopener">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%</a>.</li>
</ul>
<h2 class="wp-block-heading">How Does MrBeast Make His Money?</h2>
The core of MrBeast's fortune is his wildly successful <a href="https://m.youtube.com/channel/UCX6OQ3DkcsbYNE6H8uQQuVA">YouTube channel, which has over 386 million subscriber</a>s. Known for outlandish, high-budget videos like being buried alive for a week or paying strangers to live in a bunker his channel is also the No. 1 most-watched in the world, earning 9 billion views in 2024.
Brands clamor for exposure in his videos, often paying $2.5 to $3 million per sponsorship just to be mentioned. His manager, Marc Hustvedt, confirmed this to Time. Videos regularly bring in millions of dollars each in advertising revenue, thanks to their scale and viral reach.
Donaldson also runs other channels like Beast Philanthropy, where 100% of ad and merch profits go to charitable causes like donating $30 million in food or giving away $1 million worth of toys.
<h3 class="wp-block-heading">Amazon Prime Deal: "Beast Games"</h3>
In one of his biggest moves yet, MrBeast signed a deal with Amazon's Prime Video to create and host the reality competition series Beast Games. The partnership, reportedly worth close to $100 million, debuted in 2024 with 1,000 contestants competing for a record-breaking $5 million cash prize.
The show pulled in 50 million views within 25 days, making it Amazon's second-largest series debut that year. Despite later facing a lawsuit from several contestants alleging mistreatment during filming, the series cemented Donaldson's status as a mainstream entertainment force far beyond YouTube.
<div class="bz-widget" data-name="smartasset-widget-2"></div>
<h2 class="wp-block-heading">How Does MrBeast's Net Worth Compare to Other Creators?</h2>
At $1 billion, MrBeast stands in a league of his own, one of the few digital creators to ever cross into billionaire territory without founding a tech company or inheriting a fortune. While he's not rivaling the likes of Elon Musk or Jeff Bezos, his net worth eclipses that of many traditional celebrities and even some top-tier CEOs.
Compared to other content creators, MrBeast is far ahead. Jake and Logan Paul, who transitioned from YouTube to boxing, acting, and business ventures, have estimated net worths of <a href="https://stylecaster.com/entertainment/celebrity-news/1234810863/logan-paul-net-worth/">$150 million</a>. Even Ryan Kaji, the kid behind the wildly successful <a href="https://www.vanguardngr.com/2024/03/top-10-worlds-richest-youtubers-in-2024/">Ryan's World toy empire, is reportedly worth $100 million</a>. Donaldson's scale of reinvestment, production value, and business growth puts him on a different trajectory altogether.
MrBeast isn't just monetizing fame, he's building an empire that blends media, philanthropy, and consumer products at a scale rarely seen in creator circles. If other influencers are running personal brands, he's architecting the Disney of YouTube, and doing it faster than anyone else in the game.
<h2 class="wp-block-heading">Does MrBeast Donate to Charity?</h2>
Absolutely. In fact, philanthropy is a major part of his brand. His Beast Philanthropy YouTube channel operates with a model where all proceeds go to charity. The channel has featured large-scale donations like giving away 100 homes, adopting 100 shelter dogs, and funding multi-million-dollar food drives.
Donaldson's stated mission is to build a self-sustaining philanthropic machine fueled by content revenue. He's also collaborated with organizations like Feeding America and Team Trees, further expanding his impact beyond his own platforms.
See Next:
<ul>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/1milsaved"> The percentage may shock you</a>.</li>
<li>This Jeff Bezos-backed startup will allow you to <a href="https://www.benzinga.com/money/bezos-landlord-100-dollars">become a landlord in just 10 minutes, with minimum investments as low as $100</a>.</li>
</ul>
Image: Shutterstock

Personal Finance

MrBeast Net Worth: How Much is YouTube's Biggest Creator Worth in April 2025?

First Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRBA#NASDAQ">FRBA</a>) reported quarterly earnings of $0.37 per share which missed the analyst consensus estimate of $0.39 by 5.13 percent. The company reported quarterly sales of $30.548 million which missed the analyst consensus estimate of $31.575 million by 3.25 percent. This is a 5.37 percent decrease over sales of $32.282 million the same period last year.

FRBA

First Bank Q1 2025 GAAP EPS $0.37 Misses $0.39 Estimate, Sales $30.548M Miss $31.575M Estimate

Oklo Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>) shares are tumbling in Tuesday&#8217;s after-hours session after Sam Altman announced he is stepping down as chairman <a href="https://www.benzinga.com/quote/OKLO">of the board</a>.
What To Know: According to a CNBC <a href="https://www.cnbc.com/2025/04/22/sam-altman-steps-down-as-oklo-chair-freeing-nuclear-company-up-to-work-with-more-ai-companies.html?qsearchterm=oklo">report</a>, OpenAI&#8217;s Altman is stepping away from Oklo&#8217;s board to give the company more flexibility to go after partnerships with OpenAI and other hyperscalers. 
Oklo went public in May through a merger with <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/03/37906984/sam-altmans-under-the-radar-spac-fuses-ai-expertise-with-nuclear-energy-here-are-the-oth" target="_blank" rel="noreferrer noopener">AltC Acquisition Corp</a>, a special purpose acquisition company (SPAC) backed by Altman, who had been the chair of Oklo's board since 2015. Oklo was the only public company Altman chaired.
"As Oklo explores strategic partnerships to deploy clean energy at scale, particularly to enable the deployment of AI, I believe now is the right time for me to step down," Altman was reported to have said in a statement.
Nuclear startups surged in popularity last year as hyperscalers increasingly turned to nuclear power to meet the rising energy demands of data centers. Data centers need to have reliable power at all times and nuclear offers an emissions-free option. Many hyperscalers also have emissions-reduction goals that they are trying to meet.
&#8220;We are excited to continue working with him to bring scalable, clean energy to the AI sector and beyond, and to continue to explore strategic partnerships with leading AI companies, including potentially with OpenAI,&#8221; Oklo co-founder and COO Caroline Cochran said per CNBC.
Altman previously said he believes <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/03/37906984/sam-altmans-under-the-radar-spac-fuses-ai-expertise-with-nuclear-energy-here-are-the-oth">nuclear energy is necessary</a> to meet booming global energy demand, especially as&nbsp;<a href="https://www.benzinga.com/topic/ai" target="_blank" rel="noreferrer noopener">AI</a>&nbsp;continues to rapidly advance. His vision for a better future involves developing AI and energy in parallel.
&#8220;I&#8217;m all-in on energy. I think there&#8217;s urgent demand for tons and tons of cheap, safe, clean energy at scale,&#8221; Altman told <a href="https://www.cnbc.com/2023/07/11/sam-altman-talks-about-oklo-nuclear-microreactor-spac.html" target="_blank" rel="noreferrer noopener">CNBC</a>&nbsp;last year when Oklo announced the deal with AltC. &#8220;I don&#8217;t see a way for us to get there without nuclear … I feel like this is the most likely and the best way to get there.&#8221;
Altman met the co-founders of Oklo back in 2013 and recruited them to join tech startup accelerator company Y Combinator, where he was president from 2014 to 2019. Altman ended up leading Oklo's seed round in 2015 before joining the company's board.
OpenAI recently closed a $40 billion funding round with major investors like SoftBank and Microsoft. The financing puts OpenAI&#8217;s valuation at around $300 billion, up from $157 billion in its previous funding round.
OKLO Price Action: <a href="http://benzinga.com/quote/oklo">Oklo shares</a> were down 11.29% after-hours, trading at $19.10 at the time of publication Tuesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44933432/tesla-in-code-red-situation-as-analyst-flags-6-threats-tied-to-musks-government-role">Tesla In &#8216;Code Red Situation&#8217; As Analyst Flags 6 Threats Tied To Musk&#8217;s Government Role</a></li>
</ul>
Photo: <a href="https://www.shutterstock.com/g/jamesonwu1972">jamesonwu1972</a>/Shutterstock.

OKLO

Oklo Stock Falls As Sam Altman Steps Down As Board Chair: 'Now Is The Right Time'

You don't accidentally become one of the richest humans on Earth. And Bill Gates? He didn't just ride the personal computing wave, he helped invent it.
The Harvard dropout-turned-tech titan co-founded Microsoft in 1975, and what followed was a decades-long run of innovation, dominance, and world-shaping software. Gates stepped back from Microsoft's day-to-day operations years ago, but he's remained a fixture on the global wealth leaderboard. These days, he's traded code for causes as chairman of the Bill &amp; Melinda Gates Foundation,&nbsp; the world's largest private charitable organization and continues to make headlines for both his giving and his ever-expanding investment portfolio.
But make no mistake: the man may have stepped away from the boardroom, but his net worth still moves markets.
<h2 class="wp-block-heading">What is Bill Gates' Net Worth in April 2025?</h2>
As of April 2025, Bill Gates is worth $104.6 billion, <a href="https://www.forbes.com/profile/bill-gates/?list=rtb/">according to Forbes' Real-Time Billionaires List, ranking him #14 richest person in the world</a>. That's after donating tens of billions over the years&nbsp; including a historic <a href="https://www.cnbc.com/2022/07/13/bill-gates-donates-20-billion-to-bill-and-melinda-gates-foundation">$20 billion donation to the Gates Foundation in 2022</a>.
Even after years of large-scale philanthropy, Gates remains a heavyweight. His fortune isn't just built on Microsoft stock anymore. He's diversified across dozens of companies through his investment firm Cascade Investment LLC, including stakes in Republic Services, Deere &amp; Co., Ecolab, and even Four Seasons Hotels. In short: he's not just the Microsoft guy anymore, he's a full-blown investing mogul with a philanthropic megaphone.
Don&#8217;t Miss: 
<ul>
<li>Maximize saving for your retirement and cut down taxes: <a href="https://smartasset.com/retirement/find-a-financial-planner?utm_source=benzinga&amp;utm_campaign=ben&amp;utm_content=y2_5MilNestEgg">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.&nbsp;</li>
<li>It's no wonder Jeff Bezos holds over $250 million in art —&nbsp;<a href="https://www.masterworks.com/?ref=zdbimty&amp;utm_source=Benzinga&amp;utm_medium=affiliate&amp;utm_campaign=Benzinga+Newsgen" target="_blank" rel="noreferrer noopener">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%</a>.</li>
</ul>
<h2 class="wp-block-heading">How Much Microsoft Stock Does Bill Gates Still Own?</h2>
Back in the day, Gates owned a massive stake in Microsoft. But after stepping down from the board in 2020 and giving away shares by the billions, his holdings have slimmed down considerably. <a href="https://www.fool.com/investing/2025/03/31/billionaire-bill-gates-has-66-of-his-foundations-4/">As of 2025, he owns less than 1% of Microsoft's outstanding shares</a>.
That said, even a small slice of Microsoft (a company with a $2.5+ trillion market cap) is still worth a staggering sum. In March 2020, his Microsoft stake stood at 1.3%. Since then, much of that has been donated, mostly to fund the Gates Foundation's global health and education work.
<h2 class="wp-block-heading">How Does Bill Gates Make Money Now?</h2>
Today, Gates&#8217; wealth isn't driven by coding or corporate salaries, it's investment income. His Cascade Investment firm, managed by trusted advisors, controls tens of billions in assets across sectors. From energy to waste management to hotels, Gates' empire generates cash quietly and steadily.
Despite his net worth exceeding $100 billion, Gates has long claimed that money, past a certain point, has no utility to him. He's more interested in impact and using wealth as a lever for solving real-world problems.
<div class="bz-widget" data-name="smartasset-widget-2"></div>
<h2 class="wp-block-heading">How Does Bill Gates&#8217; Net Worth Compare to Other Billionaires?</h2>
In the tech world, Gates is still elite, but no longer at the very top of the leaderboard. Elon Musk and Jeff Bezos now jockey for first place, with net worths in the $200-$300 billion range.&nbsp;
Unlike some of his billionaire peers, Gates stepped away from his company early, gave away massive chunks of his wealth, and still came out a billionaire. That alone puts him in rare company.
He's also richer than other high-profile tech leaders like <a href="https://www.thestreet.com/personalities/sundar-pichai-net-worth">Sundar Pichai (Alphabet CEO, ~$1.3 billion)</a> and <a href="https://www.bbntimes.com/companies/meet-the-ceo-of-microsoft-satya-nadella-discover-his-net-worth-ethnicity-leadership-style-and-personal-life">Satya Nadella (Microsoft CEO, ~$1.4 billion)</a>. While those execs are compensated with stock, Gates built Microsoft from scratch and his legacy reflects it.
<h2 class="wp-block-heading">How Does Bill Gates Spend His Money, and Does He Donate to Charity?</h2>
You won't see Bill Gates flexing a fleet of Lambos or building a rocket to Mars. His home in Medina, Washington, nicknamed "Xanadu 2.0", is technologically lavish, but it's no gold-plated megamansion.
Instead, Gates is one of the most prolific philanthropists in history. He's donated over $59 billion to the Gates Foundation, funding global initiatives in vaccines, public health, sanitation, and education. And he's not done, his 2022 gift of $20 billion is just part of his plan to eventually give away the vast majority of his wealth.
Beyond the foundation, he's a member of the Giving Pledge, a commitment by billionaires to donate most of their wealth during their lifetimes. In interviews, he's said he plans to leave only a modest portion to his children, aiming to raise them with values rather than trust fund cushions.
<h2 class="wp-block-heading">What's Next for Bill Gates?</h2>
At 69 years old, Gates is focused less on business and more on global impact. He continues to write books, speak on pandemic preparedness, and champion sustainable energy. And despite stepping away from Microsoft, his opinion still carries weight in tech circles and even the stock market listens when he speaks.
See Next:
<ul>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/1milsaved"> The percentage may shock you</a>.</li>
<li>This Jeff Bezos-backed startup will allow you to <a href="https://www.benzinga.com/money/bezos-landlord-100-dollars">become a landlord in just 10 minutes, with minimum investments as low as $100</a>.</li>
</ul>

Bill Gates Net Worth: How Much is the Gates Foundation Chairman Worth in April 2025?

Macro Economic Events

Econ #s

Economics

USA API Weekly Crude Oil Stock 4.565M Barrel Draw Vs 2.4M Barrel Build Prior

Press Releases

IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update

Treatment.com AI Inc. (TRUE.CN) Advances AI in Healthcare with Strategic Moves

IGM Biosciences to Present at the Jefferies Healthcare Conference

IGM Biosciences Announces Second Quarter 2024 Financial Results and Provides Corporate Update

IGM Biosciences to Present at the Stifel 2024 Virtual Immunology and Inflammation Summit

IGM Biosciences Announces Strategic Pivot to Focus Exclusively on Autoimmunity

IGM Biosciences to Present at Three Upcoming Investor Conferences

IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update

IGM Biosciences Provides Strategic Update on Autoimmunity Pipeline Programs

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of IGM Biosciences, Inc. - IGMS

Comments

IGM Biosciences

뉴스

파트너 / 기고자

벤징가 글로벌